NAPROXENE Esoméprazole Sandoz 500mg/20mg 30 pce
7680691840012
CH-69184
M01AE52
07.10.2.
Active substances:
1 / 3
google
Details
- Product number
- 6918401
- CPT
- -
- Packaging group
- 30
- Unit
- Tablette(n)
- Composition
- naproxenum 500 mg, esomeprazolum 20 mg ut esomeprazolum magnesicum trihydricum 22.3 mg, silica colloidalis anhydrica, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, polysorbatum 80, glyceroli monostearas 40-55, triethylis citras, lactosum monohydricum 24.055 mg, carmellosum natricum conexum, natrii stearylis fumaras, cellulosum microcristallinum, magnesii oxidum leve, povidonum K 30, calcii stearas, Überzug: hypromellosum, macrogolum 400, E 171, E 172 (flavum), pro compresso obducto corresp. natrium 1.71 mg.
Articles (1)
Naproxen Esomeprazol Sandoz 500 mg / 20 mg, Filmtabletten
Filmtabletten
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
naproxenum
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
esomeprazolum
|
20.0 MG | Substance | Wirkstoff (Principe actif) |
|
esomeprazolum magnesicum trihydricum
|
22.3 MG | Substance | WIZUS |
|
silica colloidalis anhydrica
|
- | Substance | HNIDK |
|
acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum
|
- | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
glyceroli monostearas 40-55
|
- | Substance | HNIDK |
|
triethylis citras
|
- | Substance | HNIDK |
|
lactosum monohydricum
|
24.055 MG | Substance | HBESI |
|
carmellosum natricum conexum
|
- | Substance | HNIDK |
|
natrii stearylis fumaras
|
- | Substance | HNIDK |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
magnesii oxidum leve
|
- | Substance | HNIDK |
|
povidonum K 30
|
- | Substance | HNIDK |
|
calcii stearas
|
- | Substance | HNIDK |
|
hypromellosum
|
- | Substance | HNIDK |
|
macrogolum 400
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
E 171
|
- | Substance | FNIDK |
|
E 172 (flavum)
|
- | Substance | FTODK |
|
natrium
|
1.71 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 25.75
Specialties list
Yes
Generic
Yes
SL addition date:
01/10/2025
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 69184
- Drug name
- Naproxen Esomeprazol Sandoz, Filmtabletten
- Galenic form
- FILM
- ATC Code
- M01AE52
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 19/11/2024
- Authorization expiration date
- 18/11/2029
- IT number
- 07.10.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- NAPROXENE Esoméprazole Sandoz 500mg/20mg 30 pce
- Description (DE)
- NAPROXEN Esomeprazol Sandoz 500mg/20mg 30 Stk
- Market launch
- 01/09/2025
- Narcotic (BTM)
- No